Imatinib Mesylate May Improve Fasting Blood Glucose in Diabetic Ph+ Chronic Myelogenous Leukemia Patients Responsive to Treatment
Author:
Affiliation:
1. University “La Sapienza,” Rome, Italy
Publisher
American Society of Clinical Oncology (ASCO)
Subject
Cancer Research,Oncology
Link
http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2004.04.217
Reference5 articles.
1. Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia
2. Boren J, Cascante M, Marin S, et al: Gleevec (STI571) influences metabolic enzyme activities and glucose carbon flow toward nucleic acid and fatty acid synthesis in myeloid tumor cells. J Biol Chem 276:37747,2001–37753,
3. Glucose transport regulation by p210 Bcr-Abl in a chronic myeloid leukaemia model
4. EORTC Cutaneous Lymphoma Task Force
5. Rhodes CJ, White MF: Molecular insight into insulin action and secretion. Eur J Clin Investig 32:3,2002–13,
Cited by 97 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Understanding the interplay between chronic lymphocytic leukemia and type 2 diabetes;Expert Review of Hematology;2024-07-26
2. Glycaemic abnormalities induced by small molecule tryosine kinase inhibitors: a review;Frontiers in Pharmacology;2024-02-01
3. Impact of tyrosine kinase inhibitors on glucose control and insulin regulation in patients with chronic myeloid leukemia;American Journal of Physiology-Endocrinology and Metabolism;2023-03-01
4. Kinase inhibitors for cancer alter metabolism, blood glucose, and insulin;Journal of Endocrinology;2022-12
5. Sorafenib decreases glycemia by impairing hepatic glucose metabolism;Endocrine;2022-10-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3